Gaudium IVF IPO Subscribed 7X as Healthcare Startups Eye Public Markets
Gaudium IVF's IPO sees 7X subscription, signaling strong investor appetite for healthcare and fertility tech startups in the Indian public market.
Key Facts
| Detail | Value |
|---|---|
| Deal size | ₹850 crore |
| Stage | IPO |
| Sector | Gaudium Ivf |
| Coverage | Startup News |
Gaudium IVF, one of India's leading fertility and IVF chains, saw its IPO subscribed 7 times over, reflecting robust demand for healthcare startups in the public markets. The listing signals a growing trend of specialized healthcare companies going public.
IPO Details
Subscription Data:
Healthcare IPO Trend
Recent & Upcoming Health Tech IPOs:
Fertility Tech Market
India IVF Market:
What This Means
The strong subscription reflects investor confidence in India's healthcare delivery sector, which is benefiting from rising incomes, better insurance penetration, and growing health awareness.
Reported by Ananya Raghavan. Spotted an error in this story? Request a correction or email corrections@startupory.com. See our editorial policy.
Enjoyed this article?
Get weekly startup insights delivered to your inbox.
Related Articles
India Startup IPO Tracker 2026: Every DRHP, Filing and Listing
A continuously updated tracker of every Indian startup IPO in 2026 — DRHPs filed with SEBI, approvals, price bands, listing dates and post-listing performance, with the issue size for each.
Meesho IPO Opens at ₹5,400 Crore: Price Band Set at ₹1,082–1,140 per Share
Meesho opened India’s largest consumer-internet IPO of 2026 on July 26, seeking ₹5,400 crore at a valuation of about $9.8 billion, with anchor investors subscribing ₹2,380 crore a day earlier.
Groww Posts ₹1,180 Crore Q1 FY27 Revenue as Active Investors Cross 16 Million
Groww reported ₹1,180 crore in Q1 FY27 revenue and ₹342 crore in profit after tax, with active NSE clients crossing 16 million as retail participation in equities continued to broaden beyond metros.